A detailed history of Diligent Investors, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Diligent Investors, LLC holds 13,663 shares of ZTS stock, worth $2.44 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
13,663
Previous 13,702 0.28%
Holding current value
$2.44 Million
Previous $2.32 Million 2.16%
% of portfolio
0.64%
Previous 0.63%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$145.54 - $178.83 $5,676 - $6,974
-39 Reduced 0.28%
13,663 $2.37 Million
Q1 2024

May 03, 2024

SELL
$165.67 - $199.94 $66,102 - $79,776
-399 Reduced 2.83%
13,702 $2.32 Million
Q4 2023

Jan 10, 2024

SELL
$151.44 - $200.09 $30,288 - $40,018
-200 Reduced 1.4%
14,101 $2.78 Million
Q3 2023

Nov 03, 2023

SELL
$167.14 - $192.77 $50,141 - $57,831
-300 Reduced 2.05%
14,301 $2.49 Million
Q2 2023

Jul 24, 2023

SELL
$160.94 - $186.23 $4,023 - $4,655
-25 Reduced 0.17%
14,601 $2.51 Million
Q1 2023

May 10, 2023

SELL
$145.48 - $175.02 $14,402 - $17,326
-99 Reduced 0.67%
14,626 $2.43 Million
Q3 2022

Oct 14, 2022

SELL
$148.29 - $182.55 $7,414 - $9,127
-50 Reduced 0.34%
14,725 $2.18 Million
Q2 2022

Jul 13, 2022

SELL
$155.97 - $200.09 $15,908 - $20,409
-102 Reduced 0.69%
14,775 $2.54 Million
Q1 2022

Apr 26, 2022

SELL
$181.39 - $234.03 $17,957 - $23,168
-99 Reduced 0.66%
14,877 $2.81 Million
Q4 2021

Jan 21, 2022

SELL
$193.69 - $247.03 $4,842 - $6,175
-25 Reduced 0.17%
14,976 $3.66 Million
Q2 2021

Aug 12, 2021

SELL
$155.9 - $187.99 $31,180 - $37,598
-200 Reduced 1.32%
15,001 $2.8 Million
Q1 2021

Apr 23, 2021

BUY
$144.0 - $169.39 $49,680 - $58,439
345 Added 2.32%
15,201 $2.39 Million
Q4 2020

Feb 09, 2021

SELL
$157.07 - $174.35 $137,436 - $152,556
-875 Reduced 5.56%
14,856 $2.46 Million
Q3 2020

Nov 09, 2020

SELL
$137.1 - $165.37 $61,695 - $74,416
-450 Reduced 2.78%
15,731 $2.6 Million
Q2 2020

Jul 09, 2020

BUY
$111.92 - $142.53 $82,820 - $105,472
740 Added 4.79%
16,181 $2.22 Million
Q1 2020

Apr 29, 2020

SELL
$92.66 - $144.94 $27,705 - $43,337
-299 Reduced 1.9%
15,441 $1.82 Million
Q4 2019

Jan 13, 2020

SELL
$116.25 - $133.25 $148,800 - $170,560
-1,280 Reduced 7.52%
15,740 $2.08 Million
Q3 2019

Oct 22, 2019

SELL
$112.57 - $128.43 $41,650 - $47,519
-370 Reduced 2.13%
17,020 $2.12 Million
Q2 2019

Aug 01, 2019

SELL
$97.98 - $114.28 $1,665 - $1,942
-17 Reduced 0.1%
17,390 $1.97 Million
Q1 2019

May 10, 2019

SELL
$81.56 - $100.67 $3,262 - $4,026
-40 Reduced 0.23%
17,407 $1.75 Million
Q4 2018

Jan 17, 2019

SELL
$79.28 - $95.27 $241,804 - $290,573
-3,050 Reduced 14.88%
17,447 $1.49 Million
Q3 2018

Oct 26, 2018

SELL
$83.5 - $93.23 $258,850 - $289,013
-3,100 Reduced 13.14%
20,497 $1.88 Million
Q2 2018

Jul 23, 2018

SELL
$79.9 - $89.2 $11,985 - $13,380
-150 Reduced 0.63%
23,597 $2.01 Million
Q1 2018

Apr 23, 2018

SELL
$71.51 - $84.69 $107,265 - $127,035
-1,500 Reduced 5.94%
23,747 $1.98 Million
Q4 2017

Feb 12, 2018

SELL
$63.24 - $72.8 $1,075 - $1,237
-17 Reduced 0.07%
25,247 $1.82 Million
Q3 2017

Nov 09, 2017

SELL
$59.73 - $65.4 $41,811 - $45,780
-700 Reduced 2.7%
25,264 $1.61 Million
Q2 2017

Aug 11, 2017

BUY
N/A
25,964
25,964 $1.62 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.6B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Diligent Investors, LLC Portfolio

Follow Diligent Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diligent Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Diligent Investors, LLC with notifications on news.